Prospective Liver Study

Completed

• Conditions: Liver Cancer

• Registration Number: NCT01539993
• Lead Sponsor: Emory University

Brief Summary

This study is designed for patients diagnosed with Liver cancer to collect information about the relationship between types of liver cancer, methods of treatment and outcomes over time.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-11
• Study First Submitted: 2012-02-15
• Study First Submitted QC: 2012-02-27
• Study First Posted: 2012-02-28
• Primary Completion: 2014-01
• Study Completion: 2014-01
• Status Verified: 2014-05
• Last Update Submitted: 2014-05-23
• Last Update Posted: 2014-05-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• Patients diagnosed with Hepatocellular carcinoma and referred for percutaneous liver treatment.

Exclusion Criteria

• Severe liver disfunction
• Active uncontrolled infection
• Significant underlying medical of physical illness

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assess efficacy of percutaneous and transarterial treatments for liver cancer.	1 month	QOL questionnaire will be collected during follow up visit.

Secondary Outcome Measures

Name	Time	Method
long term follow up	3 months, 6 months 1year	Patients will be administered QOL during 3 months, 6 months and 1 year follow up.

Trial Locations

Locations (1)

Emory University; 🇺🇸 Atlanta, Georgia, United States